Inventor · disambiguated record
Gianni Chessari
Also filed as: CHESSARI GIANNI
32 granted patents·19 pending applications·242 citations·filing 2005–2024
97Inventor score
Files withASTEX THERAPEUTICS LTD30ASTRAZENECA AB9CHESSARI GIANNI5ALBERT JEFFREY1ALBERT JEFFREY SCOTT1
Top patents by PatentIndex Score
51 records- 0196US7754725B2Dihydroxyphenyl isoindolymethanonesASTEX THERAPEUTICS LTD·Filed 2007·Granted Jul 13, 2010·22 cites·10 claims
- 0295US10544132B2Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2016·Granted Jan 28, 2020·10 cites·27 claims
- 0395US9458158B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2015·Granted Oct 4, 2016·11 cites·22 claims
- 0495US8106057B2Dihydroxyphenyl isoindolylmethanonesCHESSARI GIANNI·Filed 2010·Granted Jan 31, 2012·19 cites·7 claims
- 0594US7700625B2Hydroxybenzamide derivatives and their use as inhibitors of Hsp90ASTEX THERAPEUTICS LTD·Filed 2007·Granted Apr 20, 2010·25 cites·10 claims
- 0693US11225476B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2020·Granted Jan 18, 2022·3 cites·13 claims
- 0792US11866428B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2020·Granted Jan 9, 2024·2 cites·21 claims
- 0892US10981898B2Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2019·Granted Apr 20, 2021·4 cites·27 claims
- 0992US10526311B2Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2016·Granted Jan 7, 2020·6 cites·25 claims
- 1092US9617248B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2013·Granted Apr 11, 2017·10 cites·20 claims
- 1192US8101648B2Hydroxybenzamide derivatives and their use as inhibitors of HSP90CHESSARI GIANNI·Filed 2006·Granted Jan 24, 2012·20 cites·18 claims
- 1291US9980973B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2017·Granted May 29, 2018·6 cites·21 claims
- 1391US9783538B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2014·Granted Oct 10, 2017·12 cites·53 claims
- 1490US11643410B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2021·Granted May 9, 2023·1 cites·22 claims
- 1590US9676768B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2015·Granted Jun 13, 2017·8 cites·16 claims
- 1690US9155743B2Bicyclic heterocycle compounds and their uses in therapyBUCK ILDIKO MARIA·Filed 2012·Granted Oct 13, 2015·12 cites·18 claims
- 1789US8530469B2Therapeutic combinations of hydroxybenzamide derivatives as inhibitors of HSP90CHESSARI GIANNI·Filed 2011·Granted Sep 10, 2013·11 cites·21 claims
- 1889US2025296930A1Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 1987US10618895B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2017·Granted Apr 14, 2020·4 cites·33 claims
- 2087US9018214B2Bicyclic heterocycle compounds and their uses in therapyWOOLFORD ALISON JO-ANNE·Filed 2012·Granted Apr 28, 2015·13 cites·21 claims
- 2186US9617283B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2013·Granted Apr 11, 2017·10 cites·20 claims
- 2285US11261171B1Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2019·Granted Mar 1, 2022·2 cites·24 claims
- 2385US7629356B2Substituted pyrrolo[3,4-b]pyridinamines and pharmaceutical compositionsASTRAZENECA AB·Filed 2008·Granted Dec 8, 2009·9 cites·19 claims
- 2485US2024199607A1Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 2584US12202828B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2022·Granted Jan 21, 2025·0 cites·48 claims
- 2684US11236047B2Combination of isoindolinone derivatives with SGI-110ASTEX THERAPEUTICS LTD·Filed 2018·Granted Feb 1, 2022·2 cites·21 claims
- 2784US9663512B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2013·Granted May 30, 2017·8 cites·18 claims
- 2883US11466016B2Pharmaceutical compoundsOTSUKA PHARMA CO LTD·Filed 2019·Granted Oct 11, 2022·2 cites·27 claims
- 2982US7855213B2CompoundsASTRAZENECA AB·Filed 2007·Granted Dec 21, 2010·7 cites·16 claims
- 3082US2025092027A1Isoindolinone inhibitors of the mdm2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 3178US8816087B2Hydroxybenzamide derivatives and their use as inhibitors of Hsp90CHESSARI GIANNI·Filed 2007·Granted Aug 26, 2014·2 cites·15 claims
- 3270US12071429B2Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2021·Granted Aug 27, 2024·0 cites·27 claims
- 3367US2022106287A1Isoindolinone inhibitors of the mdm2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 3467US2019375748A1Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 3566US9914719B2Hydroxybenzamide derivatives and their use as inhibitors of HSP90ASTEX THERAPEUTICS LTD·Filed 2014·Granted Mar 13, 2018·0 cites·21 claims
- 3663US8598217B2Imidazole derivatives and their use as modulators of cyclin dependent kinasesHOWARD STEVEN·Filed 2010·Granted Dec 3, 2013·1 cites·18 claims
- 3761US2017334907A1Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2017·Application pending·0 cites
- 3856US2010324072A1Pyrrolopyridine derivatives and their use as bace inhibitorsASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 3954US2024239788A1Small molecule inhibitors of kras g12d mutantMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 4054US2010216782A1Hydroxybenzamide derivatives and their use as inhibitors of hsp90CHESSARI GIANNI·Filed 2010·Application pending·0 cites
- 4147US2009215777A1Pyrimidine Derivatives As HSP90 InhibitorsASTEX THERAPEUTICS LTD·Filed 2006·Application pending·0 cites
- 4244US2009176850A1Novel 2-Amino-Imidazole-4-One Compounds And Their Use In The Manufacture Of A Medicament To Be Used In The Treatment Of Cognitive Impairment, Alzheimer's Disease, Neurodegeneration And DementiaASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 4343US2009233930A9Novel 2-Amino-Imidazole-4-One Compounds and Their Use in the Manufacture of a Medicament to Be Used in the Treatment of Cognitive Impairment, Alzheimer's Disease, Neurodegeneration and DementiaASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 4443US2008255167A1Novel 2-Aminopyrimidine or 2-Aminiopyridinone Derivatives and Their UseALBERT JEFFREY·Filed 2006·Application pending·0 cites
- 4543US2008293709A1Novel 2-Amino-Heterocycles Useful in the Treatment of Abeta-Related PathologiesASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 4642US2011059992A1New CompoundsASTRAZENECA AB·Filed 2010·Application pending·0 cites
- 4742US2009221579A1Substituted Amino-Compounds and Uses ThereofALBERT JEFFREY SCOTT·Filed 2005·Application pending·0 cites
- 4842US2008287399A1Substituted Aminopyridines and Uses ThereofASTRAZENECA AB·Filed 2005·Application pending·0 cites
- 4941US2009062282A1Substituted Amino-Pyrimidones and Uses ThereofASTRAZENECA AB·Filed 2005·Application pending·0 cites
- 5039US2014288040A1Substituted benzylamine compounds, their use in medicine, and in particular the treatment of hepatitis c virus (hcv) infectionASTEX THERAPEUTICS LTD·Filed 2012·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Gianni Chessari files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →